Grupo farmacéutico · Reino Unido
Hikma
Un grupo de 14 empresas con 688 medicamentos en 7 países.
Estructura del grupo
14 empresas en 6 países
Cargando la página…
Cargando la página…
Grupo farmacéutico · Reino Unido
Un grupo de 14 empresas con 688 medicamentos en 7 países.
14 empresas en 6 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 688
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION USP9 mg / ml · Solution | Sodium chloride | Canadá | Comercializado | 2008 |
| ABIRATERONE ACETATE125mg | 250mg | 500mg · Tablet | Abiraterone | Estados Unidos | Comercializado | 2018 |
| ACETYLCYSTEINE SOLUTION USP200 mg / ml · Solution | Acetylcysteine | Canadá | Comercializado | 2018 |
| ACICLOVIR HIKMAPolvere per soluzione per infusione endovenosa | Aciclovir | Italia | Autorizado | |
| Aciclovir Hikma 250 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Aciclovir | Países Bajos | Autorizado | 2022 |
| ACICLOVIR HIKMA 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG250 mg · Polvo para solución para perfusión | Aciclovir | España | Comercializado | 2018 |
| Aciclovir Hikma 500 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Aciclovir | Países Bajos | Autorizado | 2022 |
| ACIDO ZOLEDRONICO HIKMAConcentrato per soluzione per infusione | Zoledronic acid | Italia | Autorizado | |
| ADENOSINA HIKMASoluzione iniettabile | Adenosine | Italia | Autorizado | |
| ADENOSINA HIKMA 6 MG/2ML SOLUCION INYECTABLE EFG3 mg/ml · Solución inyectable | Adenosine | España | Comercializado | 2021 |
| ADENOSINE3mg/ml · Injectable | Adenosine | Estados Unidos | Comercializado | 2004 |
| Adenosine Hikma 6 mg/2 ml, oplossing voor injectieOplossing voor injectie | Adenosine | Países Bajos | Autorizado | 2021 |
| ALENDRONATE SODIUM70mg base/75ml · Solution | Alendronic acid | Estados Unidos | Comercializado | 2013 |
| ALOPERIDOLO HIKMASoluzione iniettabile a rilascio prolungato | Haloperidol | Italia | Autorizado | |
| ALPRAZOLAM1mg/ml · Concentrate | Alprazolam | Estados Unidos | Comercializado | 1993 |
| ALPROSTADIL0.5mg/ml · Injectable | Alprostadil | Estados Unidos | Comercializado | 1998 |
| AMFOTERICINA B LIPOSOMAL HIKMA 50 MG POLVO PARA CONCENTRADO PARA DISPERSION PARA PERFUSION50 mg · Polvo para dispersión para perfusión | Amphotericin b | España | Autorizado | 2026 |
| AMICAR1gm | 500mg · Tablet | Aminocaproic acid | Estados Unidos | Comercializado | 1964 |
| AMICAR0.25gm/ml · Solution | Aminocaproic acid | Estados Unidos | Comercializado | 1964 |
| AMINOCAPROIC500mg · Tablet | Aminocaproic acid | Estados Unidos | No comercializado | 2001 |
| Amiodaron HCl Hikma, 50 mg/ml oplossing voor injectieOplossing voor injectie | Amiodarone | Países Bajos | Autorizado | 2007 |
| AMIODARONE HIKMASoluzione iniettabile | Amiodarone | Italia | Autorizado | |
| AMOXICILLIN125mg/5ml | 200mg/5ml | 250mg/5ml | 400mg/5ml · For suspension | Amoxicillin | Estados Unidos | Comercializado | 1978 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM125mg/5ml; 31.25mg base/5ml | 200mg/5ml; 28.5mg base/5ml | 250mg/5ml; 62.5mg base/5ml | 400mg/5ml; 57mg base/5ml | 600mg/5ml; 42.9mg base/5ml · For suspension | Amoxicillin, Clavulanic acid | Estados Unidos | Comercializado | 2002 |
| ANIDULAFUNGINA HIKMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG100 mg · Polvo para concentrado para solución para perfusión | Anidulafungin | España | Autorizado | 2026 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Arabia Saudí | 193 | 193 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 162 | 158 | 4 | EmpresasTodos los medicamentos |
| Canadá | 105 | 95 | 10 | EmpresasTodos los medicamentos |
| Países Bajos | 89 | 89 | 0 | EmpresasTodos los medicamentos |
| España | 74 | 73 | 1 | EmpresasTodos los medicamentos |
| Italia | 64 | 64 | 0 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 1 | 1 | 0 | EmpresasTodos los medicamentos |
También en los registros de Brasil, Croacia, Francia, Reino Unido, Serbia, Singapur
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Hikma en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.